Drug shows promise for relapse remitting MS
Posted: Mon Mar 13, 2017 8:25 am
Apitope, a drug discovery and development company, has revealed ATX-MS-1467 reduced the number and volume of brain lesions with a promising safety profile in relapse remitting MS (RRMS) patients...Read more - http://www.ms-uk.org/drug-shows-promise ... -ms-130317